A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679

NCT00511563 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Cancelled before active due to the results of emerging scientific data

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: GW876008 and GSK561679

Sponsor

GlaxoSmithKline